InsidersTradesSigma
SpectraCure AB (publ): directors' dealings · Finland · FIN-FSA
FI:spectracure-ab-publ-0d2114SE0025165699FI·FIN-FSAMcap 25M€Healthcare
Explore the full directors' dealings record of SpectraCure AB (publ), a publicly traded company based in Finland. Shares trade on FI FI, under the authority of FIN-FSA. Operating in the Healthcare sector, SpectraCure AB (publ) has logged 7 reports. Market capitalisation: €25m. The latest transaction was filed on 24 January 2026 (Purchase). Among the most active insiders: Masoud Khayyami. The full history is openly available.
7
Insider Decl.
0
Thresholds
€77,276
6 ops.
Buy Volume
€4,133
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
0.06 €
Analyst consensus
Income statement
Gross profit12.4 M€
Net income−56.1 M€0.0% margin
Valuation
P/Book0.2x
Balance sheet & cash
Market cap25.0 M€
Total debt2.8 M€
Free Cash Flow−43.7 M€
Debt / Equity3%
Profitability & ownership
ROE-40.2%
% insiders14.8%
% institutions2.4%
Last declaration on 24 January 2026
Declarations7 total
Executives●Purchase21FIN-FSA
€52,4705,555,555 shares@ €0.00940.21% mcap68.0% of flow
Aktie
FI:A003V448-1·
Ideal exit: 20 Oct 2026 (T+270)
Executives●Purchase10FIN-FSA
€5,962529,876 shares@ €0.01130.024% mcap7.7% of flow
Aktie
FI:A003V236-1·
Ideal exit: 6 Oct 2026 (T+270)
Executives●Purchase11FIN-FSA
€8,271662,685 shares@ €0.01250.033% mcap10.7% of flow
Aktie
FI:A003V202-1·
Ideal exit: 5 Oct 2026 (T+270)
Executives●Sale33FIN-FSA
€4,133300,000 shares@ €0.01380.017% mcap100.0% of flow
Aktie
FI:A003V112-1·
Executives●Purchase21FIN-FSA
€1,483351,190 shares@ €0.00420.0059% mcap1.9% of flow
Aktie
FI:A003U951-1·
Ideal exit: 15 Sept 2026 (T+270)
Executives●Purchase13FIN-FSA
€9,012592,260 shares@ €0.01520.036% mcap11.7% of flow
Aktie
FI:A003U637-1·
Ideal exit: 4 Sept 2026 (T+270)
Executives●Purchase16FIN-FSA
€784,809 shares@ €0.01620.0003% mcap100.0% of flow
BTU (betald tecknad unit)
FI:A003Q127-1·
Ideal exit: 16 Mar 2026 (T+270)
7 of 7 declarations